mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |